RNA

NASDAQ open

Atrium Therapeutics

6.91 USD
▼-0.07-1.00%
盘后 8.26 0.00%
2026-11-20
市值
$149.27M
市盈率
—
EPS
-4.28
股息率
—
52 周区间
6.36 – 16.77
成交量
212.76K
Beta
0.93
目标价
22.00
52W 低 6.3652W 高 16.77
价格走势

公司简介

Atrium Therapeutics, Inc., a biopharmaceutical company, focuses on delivering ribonucleic acid (RNA) therapeutics to the heart to transform the care for people living with cardiomyopathies. The company’s development stage product candidates include ATR 1072, a siRNA-based therapy targeting PRKAG2 for the treatment of PRKAG2 syndrome; and ATR 1086, a siRNA-based therapy targeting PLN for the treatment of PLN cardiomyopathy. It also focuses on pipeline to treat a range of genetic and cardiac diseases. It has a research collaboration and license a...